BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  CR Pharma In-licenses Rights to Prostate Cancer Drug From Xbrane

  CR Pharma will be responsible for China clinical trials and other regulatory matters.

  February 7, 2018

   · 

  1 min read
• Business

  Chengdu’s NetVation DL Forms Partnership With Pfizer

  NetVation DL Medicine, a privately held Chengdu biotech, has entered a two-year research collaboration with Pfizer.

  February 7, 2018

   · 

  1 min read
• China’s Luqa Pharma Closes $15M B Round for Dermatology/Aesthetic Products

  Luqa Pharma of Hong Kong closed a $15M Series B financing round led by Cenova Capital.

  February 7, 2018

   · 

  1 min read
• Business

  Jing Medicine Forms $100 Million Collaboration with ShanghaiTech University

  Jing Medicine Technology will collaborate with ShanghaiTech University in a $100M partnership to discover and develop novel small molecule cancer drugs.

  February 7, 2018

   · 

  1 min read
• Biotech Bay

  Exelixis Announces Updated Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Genitourinary (GU) Tumors

  The primary endpoint of the trial is to determine the dose-limiting toxicity and recommended phase 2 doses of the doublet and triplet combinations.

  February 7, 2018

   · 

  17 min read
• Business

  Lundbeck Delivers Its Best Financial Results Following 10% Revenue Growth and 117% Growth in Net Profit

  Revenue reached DKK 17,234 million in 2017 representing an increase of 10% (12% in local currencies) compared to 2016 .

  February 7, 2018

   · 

  2 min read
• Sinovac Holds 2017 Annual General Meeting of Shareholders

  Sinovac Biotech announced today that it held its 2017 Annual General Meeting of Shareholders on Tuesday, February 6, 2018 in Beijing, PRC.

  February 7, 2018

   · 

  2 min read
• Sinovac Provides Update on Going Private Transaction

  Attached as an exhibit to the Going-Private Statement is a preliminary proxy statement.

  February 7, 2018

   · 

  4 min read
• Drug Development

  Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine

  The results show markedly higher blood plasma concentrations when betahistine administered intranasally rather than orally.

  February 7, 2018

   · 

  5 min read
• Business

  Advanced Proteome Therapeutics and ImmunoBiochem Corporation Enter Into a Collaboration and Option Agreement

  The companies will evaluate the prospect of combining ImmunoBiochem’s proprietary antibody and APC’s site-selective conjugation technology to produce ADCs with superior properties, targeting triple-negative breast cancer.

  February 7, 2018

   · 

  4 min read